PACB vs XEL · rev $76.2M vs P/E 20, $39.33B cap
Pacific Biosciences of California (PACB) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
XEL does not have a complete income-statement cache yet.
PACB currently screens at market cap $387.1M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the PACB and XEL stock pages for the full models.
Not investment advice.